GALNS rs118204440: Understanding Carrier Status
The rs118204440 variant is a genetic mutation located within the GALNS gene. It is recognized in clinical databases as a pathogenic variant associated with carrier status for Mucopolysaccharidosis type IV-A.
What each genotype means
Typical GALNS genotype
This genotype represents the common, non-pathogenic sequence at this location in the GALNS gene. It is not associated with the carrier status for Mucopolysaccharidosis type IV-A.
This is the most common genotype found in the general population.
Carrier of MPS-IV-A mutation
This genotype indicates you carry one copy of a pathogenic variant in the GALNS gene. This condition is inherited in an autosomal recessive manner, meaning carriers typically do not show symptoms of Mucopolysaccharidosis type IV-A, but should discuss the implications of this carrier status with a genetic counselor or physician.
This genotype is rare in the general population.
Potential MPS-IV-A risk
This genotype indicates the presence of two copies of the pathogenic variant in the GALNS gene. This variant is linked to Mucopolysaccharidosis type IV-A, a condition caused by a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase. Please consult with a medical professional or clinical geneticist to discuss these findings and their clinical relevance.
This genotype is extremely rare in the general population.
What is rs118204440?
The variant rs118204440 is a specific change in the DNA sequence located on chromosome 16. In genetic databases, it is identified by its rsID, which serves as a unique label for researchers to track this specific position in the human genome. This variant sits within the GALNS gene, which provides instructions for the body to create a specific enzyme. When a change occurs at this location, it can alter the function of the resulting protein. Because this variant is classified as pathogenic in clinical settings, it is studied primarily for its role in hereditary conditions. Understanding where this variant sits helps scientists and clinicians determine how it might impact biological processes, though it is important to note that the presence of a variant does not automatically result in a clinical diagnosis.
The Role of the GALNS Gene
The GALNS gene is responsible for producing an enzyme called N-acetylgalactosamine-6-sulfatase. This enzyme is essential for the proper function of lysosomes, which are the recycling centers of the cell. Specifically, the enzyme helps break down complex sugar molecules known as glycosaminoglycans, such as keratan sulfate and chondroitin-6-sulfate. When the GALNS gene is not functioning correctly due to pathogenic mutations, these sugar molecules cannot be broken down efficiently. Over time, this leads to an accumulation of these substances within cells, which can interfere with normal cellular function and tissue development. This underlying mechanism is the primary cause of Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, a condition that affects skeletal development and other bodily systems.
Research and Clinical Evidence
Research into rs118204440 has established it as a pathogenic variant linked to Mucopolysaccharidosis type IV-A. Clinical evidence, such as that found in the ClinVar database, classifies this variant based on its potential to disrupt the GALNS enzyme's activity. Mucopolysaccharidosis type IV-A is an autosomal-recessive disorder, meaning that an individual typically needs to inherit two copies of a pathogenic mutation—one from each parent—to manifest the symptoms of the condition. As a carrier, an individual possesses one copy of the variant and one functional copy of the gene, which usually prevents the development of the disease. The evidence strength for this variant is considered moderate, reflecting its documented role in clinical literature. Because genetic conditions are complex, researchers continue to study how different mutations within the GALNS gene contribute to the wide spectrum of clinical severity observed in patients.
Population Frequency and Interpretation
The rs118204440 variant is classified as rare in the general population. Because it is a rare variant, it is not commonly found in large-scale genomic studies of the general public. When a variant is rare, its frequency can vary significantly between different ancestral groups, and it is often identified through targeted testing of individuals with a family history of related conditions or through clinical diagnostic screening. It is important to remember that being a carrier for a recessive condition is common, as most people carry several rare, recessive variants in their genome. This information is intended for educational purposes and should not be used to diagnose any medical condition. If you have concerns about your genetic status or family history, the most appropriate step is to consult with a qualified genetic counselor or a medical professional who can provide personalized guidance.
How common is this variant?
The rs118204440 variant is considered rare across global populations, appearing infrequently in standard genomic databases.
Frequently asked questions
What does it mean to be a carrier for Mucopolysaccharidosis type IV-A?
Being a carrier means you have one copy of a pathogenic variant in the GALNS gene, but you also have one functional copy. Carriers typically do not show symptoms of the condition because the functional copy provides enough enzyme activity for the body's needs.
Can I use this information to diagnose myself?
No, genetic variants identified in reports should not be used for self-diagnosis. Clinical diagnosis of genetic conditions requires professional medical evaluation, physical examination, and often specialized biochemical testing.
Should I be worried if I have this variant?
Finding a rare variant can be concerning, but it is important to discuss the results with a healthcare provider or a genetic counselor. They can help put the information into the context of your personal and family health history.
How is Mucopolysaccharidosis type IV-A inherited?
It is inherited in an autosomal-recessive pattern. This means that a child must inherit one pathogenic mutation from each parent to be affected by the condition.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs118204440?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29